DNI-GLU*TFA

Technology Overview

This dinitro-indoline-masked form of glutamate releases the bioactive glutamate more rapidly than any other commercially available compound. It was developed for high-quantum yield requiring less irradiation for release, so its effective concentration is lower than other caging scaffolds. The caged compound exists as trifluoroacetic acid salted form (DNI-Glu*TFA) ensuring good solubility, stability and low hygroscopicity. DNI-Glu is a compound developed in-house, only available from Femtonics.

See more at Uncaging.

Features

  • Photostimulation with two-photon laser
  • High quantum-yield
  • Effective at low concentration
  • Seven-fold higher quantum yield than any other caged form
  • Stable and soluble
  • Primarily used for in vitro experiments

Benefits

    • High excitatory postsynaptic potential and high Ca2+ transient as a response to the photo release
    • Less illumination is sufficient to elicit the same response as with alternative compounds
    • Elicits large transients or regenerative activity
    • Applicable for receptor mapping experiments

References

 

 

 

 

  • High efficiency two-photon uncaging coupled by the correction of spontaneous hydrolysis.
    Dénes Pálfi, Balázs Chiovini, Gergely Szalay, Attila Kaszás, Gergely F. Turi, Gergely Katona, Péter Ábrányi-Balogh, Milán Szőri, Attila Potor, Orsolya Frigyesi, Csilla Lukácsné Haveland, Zoltán Szadai, Miklós Madarász, Anikó Vasanits-Zsigrai, Ibolya Molnár-Perl, Béla Viskolcz, Imre G. Csizmadia, Zoltán Mucsi and Balázs Rózsa, Org. Biomol. Chem. (2018)